Actos pioglitazone: Completed Phase III enrollment

Takeda and Zinfandel (Chapel Hill, N.C.) completed enrollment of about 3,500 patients ages 65-83 in the double-blind, placebo-controlled, international Phase III

Read the full 216 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE